Gilead Sciences (GILD) Tops Q4 EPS by 17c; Guides
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $138.24 +1.74%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $1.67, $0.17 better than the analyst estimate of $1.50. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $6.66 billion.
GUIDANCE:
Gilead Sciences sees FY2023 EPS of $6.60-$7.00, versus the consensus of $6.73. Gilead Sciences sees FY2023 revenue of $26-26.5 billion, versus the consensus of $27 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c
- Intellicheck (IDN) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
